Russian Federation vs Singapore: Measles-containing-vaccine first-dose (MCV1) immunization coverage
Russian Federation
97.0%
in 2025
Singapore
97.0%
in 2025
Russian Federation rank
33rd
Singapore rank
33rd
Measles-containing-vaccine first-dose (MCV1) immunization coverage over time
- Russian Federation
- Singapore
How they compare
Russian Federation currently reports 97.0% against 97.0% in Singapore, a difference of 0.0%.
The two have swapped places 3 times across 26 shared years of data; in 2000 it was Russian Federation ahead.
Russian Federation ranks 33rd and Singapore ranks 33rd of 194 countries.
Russian Federation has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Russian Federation | Singapore | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 98.2% | 94.9% | 3.3% | Russian Federation |
| 2010s | 98.0% | 95.3% | 2.7% | Russian Federation |
| 2020s | 97.0% | 96.7% | 0.3% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine first-dose (mcv1) immunization coverage, Russian Federation or Singapore?
- Russian Federation, at 97.0% against 97.0% in Singapore as of 2025.
- What is the difference in measles-containing-vaccine first-dose (mcv1) immunization coverage between Russian Federation and Singapore?
- 0.0%, with Russian Federation ahead.
- How many years of comparable data are there for Russian Federation and Singapore?
- 26 years are reported by both, from 2000 to 2025.
- How do Russian Federation and Singapore rank globally for measles-containing-vaccine first-dose (mcv1) immunization coverage?
- Russian Federation ranks 33rd and Singapore ranks 33rd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.